top of page
Meeting

EQUITY / PARTNERSHIPS

120

OVER

YEARS

At iWisdom, we empower biotech companies to unlock their full potential through strategic partnerships and expert guidance. With over 120 years of combined experience, we specialize in transforming innovative ideas into valuable market-ready solutions.

OUR PRODUCTS

Opportunity icon GREY

Opportunity

Screening

Finding, prioritizing and executing strategic investments​

Equity icon GREY

Corporate ​
Strategy

Achieving full company potential for maximal value extraction​

Investor 2 icon GREY

Fundraising & Investor Relations

Raising the right amount of funds at the right time with the right investors

Strategy icon

Partnerships

​

iWisdom is a partner to the team  â€‹

​

IWISDOM IS A PARTNER TO THE TEAM 

Partnering with a biotech company as part of the management team, providing support from early-stage development through to commercialization or exit.

STAKEHOLDERS

OPERATIONAL

MANAGEMENT

APPROACH

•Conduct an on-site diagnostic to assess asset potential and company operations.
 

• Develop a business model aligned with board objectives.

​

• Forecast revenues and prioritize high-potential assets.

​

• Accelerate clinical trials to secure proof of concept and enhance company value.

​

• Establish partnerships with big pharma to diversify revenue streams.

​

• Raise funds and invest strategically to boost valuation.

​

• Go to market or exit strategy.

KEY OUTCOMES

• Ensuring mutual growth with the client aligned with its goals.

​

• iWisdom is a shareholder

SOLUTIONS

• All iWisdom products can be used when an equity partnership is signed with a company. 
 

• Develop replicable growth framework such as “team structure, platform development, portfolio strategy, and Funding & partnerships” associated with in depth financial analysis.

Screenshot 2024-10-17 140801.png

OPTIMAL VALUE EXTRACTION

Transforming a early-stage biotech into a $500M + company

Screenshot 2024-10-17 140801.png

OPERATIONAL OPTIMIZATION

Ensuring organizational efficiency from the outset.

Screenshot 2024-10-17 140801.png

RISK MANAGEMENT

Reducing risks such as sustainability, regulatory, R&D and clinical. 

bottom of page